Brian Spaly - 01 Jul 2025 Form 4 Insider Report for AZEK Co Inc. (AZEK)

Reporting relationship: Director
Issuer ticker: AZEK
Reported as of: 01 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2025, 06:30:07 UTC
Prior SEC filing: 05 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Morgan Walbridge, as Attorney-in-Fact for Brian Spaly

Key filing fact

Brian Spaly filed Form 4 for AZEK Co Inc. (AZEK) on 02 Jul 2025.

Key facts

This page summarizes Brian Spaly's Form 4 filing for AZEK Co Inc. (AZEK).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 02 Jul 2025, 06:30.

Change

Previous filing in this sequence was filed on 05 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001743518 Primary reporting owner

Spaly Brian

Relationship: Director
Address: 1330 W. FULTON ST., SUITE 350, CHICAGO
Signature: /s/ Morgan Walbridge, as Attorney-in-Fact for Brian Spaly
Signature date: 02 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AZEK transaction

Class A Common Stock

Disposed to Issuer

Transaction value
Shares: -80,756
Change %: -100%
Price
Shares after: 0
Date: 01 Jul 2025
Ownership: Direct
Footnotes: F1, F2, F3

AZEK transaction

Class A Common Stock

Disposed to Issuer

Transaction value
Shares: -4,974
Change %: -100%
Price
Shares after: 0
Date: 01 Jul 2025
Ownership: Direct
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Brian Spaly is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

Represents shares (including in respect of shares underlying, as applicable, Company RSU Awards, Company PSU Awards and Company Stock Options (each as defined in the Agreement and Plan of Merger, dated as of March 23, 2025 (as amended, the "Merger Agreement"), by and among The AZEK Company Inc. ("AZEK"), James Hardie Industries plc ("JHX") and Juno Merger Sub Inc.)) disposed of pursuant to the closing of the transactions contemplated by the Merger Agreement.

Footnote F2

In accordance with the Merger Agreement, upon the Effective Time (as defined in the Merger Agreement), each share of Company Common Stock (as defined in the Merger Agreement) that was issued and outstanding immediately prior to the Effective Time (subject to certain exceptions) was converted into the right to receive $26.45 in cash, without interest (the "Cash Consideration"), and 1.0340 (the "Exchange Ratio") JHX ordinary shares, with cash in lieu of fractional JHX ordinary shares, where any such aggregated fractional shares are rounded to four (4) decimal places and multiplied by JHX's five-trading day volume-weighted average price ending on June 30, 2025, the trading day immediately prior to the closing of the transactions contemplated by the Merger Agreement (the "Parent Share Price") (collectively, the "Merger Consideration"). The Parent Share Price was $26.053018.

Footnote F3

Upon the Effective Time, each then-outstanding Company RSU Award held by the reporting person was fully vested and canceled in exchange for the right to receive the Merger Consideration.

Footnote F4

In connection with the closing of the merger, the deferred stock units held by the reporting person as of immediately prior to the Effective Time were settled and immediately cancelled in exchange for the Merger Consideration.